Fulgent Genetics rises after FY revenue forecast raise, Q3 revenue beat

Fulgent Genetics

07/11/2025 13:32

** Shares of genetic testing company Fulgent Genetics FLGT.O rise 7.6% to $24 premarket

** Co raises FY revenue forecast to $325 million, compared to a previous view of $320 million, analysts expect annual revenue of $320.12 million as per LSEG-compiled data

** Co posts Q3 revenue of $84.07 million, vs an estimate of $81.4 million

** As of last close, FLGT stock was up 20.8% YTD

 (Reporting by Padmanabhan Ananthan)

 ((Padmanabhan.Ananthan@thomsonreuters.com))